Table 5.
Comparing IgG and IgM Borrelia seropositivity among patient groups with persistent symptoms attributed to Lyme disease, healthy controls, and patients in primary care.
| PSL n = 40 (%) |
HC n = 40 (%) |
GP n = 41 (%) |
p-Value | ||
|---|---|---|---|---|---|
| Positive Serion screening ELISA | IgG | 23 (58) | 2 (5) | 32 (78) | <0.001 * 0.098 # |
| IgM | 16 (39) | 2 (5) | 16 (39) | <0.001 * 0.589 # |
|
| Positive Euroimmun EUROLINE–WB | IgG | 27 (68) | 3 (8) | 34 (83) | <0.001 * 0.176 # |
| IgM | 18 (45) | 2 (5) | 15 (37) | <0.001 * 0.326 # |
|
Data are presented as numbers and (percentages). Statistical analysis used was Pearson’s Chi square test; * = p-value difference between PSL and HC, # = p-value difference between PSL and GP. PSL—patient group with persistent symptoms attributed to Lyme disease; HC—healthy controls; GP—patients in primary care.